Dana-Farber researchers to present findings at 2022 ASCO Genitourinary Cancers Symposium
Dana-Farber Cancer InstituteDana-Farber Cancer Institute researchers will present important research studies during the 2022 ASCO Genitourinary (GU) Cancers Symposium. The Dana-Farber led research exemplifies innovative and multidisciplinary expertise in prostate, kidney, and bladder cancers, and includes studies examining quality of life and the impact of the COVID-19 pandemic specifically on GU malignancies.